tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Technical Analysis

Compare
733 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Protagonist Therapeutics’s (PTGX) Moving Averages Convergence Divergence (MACD) indicator is -0.66, suggesting Protagonist Therapeutics is a Sell.
Protagonist Therapeutics’s (PTGX) 20-Day exponential moving average is 83.43, while Protagonist Therapeutics’s (PTGX) share price is $85.59, making it a Buy.
Protagonist Therapeutics’s (PTGX) 50-Day exponential moving average is 83.28, while Protagonist Therapeutics’s (PTGX) share price is $85.59, making it a Buy.

Protagonist Therapeutics (PTGX) Pivot Points

Feb 04, 2026, 06:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
77.87
79.50
81.28
82.91
84.69
86.32
88.10
Fibonacci
79.50
80.81
81.61
82.91
84.22
85.02
86.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Protagonist Therapeutics (PTGX) Moving Averages

Feb 04, 2026, 06:39 PM
Period
Simple
Exponential
MA5
82.39Buy
83.31Buy
MA10
82.91Buy
83.01Buy
MA20
82.56Buy
83.43Buy
MA50
86.09Sell
83.28Buy
MA100
79.39Buy
78.49Buy
MA200
65.70Buy
67.26Buy
Protagonist Therapeutics’s (PTGX) 10-Day exponential moving average is 83.01, while Protagonist Therapeutics’s (PTGX) share price is $85.59, making it a Buy.
Protagonist Therapeutics’s (PTGX) 100-Day exponential moving average is 78.49, while Protagonist Therapeutics’s (PTGX) share price is $85.59, making it a Buy.
Protagonist Therapeutics’s (PTGX) stock price is $85.59 and Protagonist Therapeutics’s (PTGX) 50-day simple moving average is 86.09, creating a Sell signal.
Protagonist Therapeutics’s (PTGX) stock price is $85.59 and Protagonist Therapeutics’s (PTGX) 100-day simple moving average is 79.39, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) stock price is $85.59 and Protagonist Therapeutics’s (PTGX) 200-day simple moving average is 65.70, creating a Buy signal.

Protagonist Therapeutics (PTGX) Technical Indicators

Feb 04, 2026, 06:39 PM
Name
Value
Implied Action
RSI (14)
54.93
Neutral
STOCH (9,6)
71.73
Neutral
STOCHRSI (14)
59.36
Neutral
MACD (12,26)
-0.66
Sell
ADX (14)
19.50
Buy
Williams %R
-18.98
Sell
CCI (14)
132.71
Sell
ATR (14)
3.31
-
Ultimate Oscillator
57.58
Neutral
ROC
5.20
Buy
Protagonist Therapeutics’s (PTGX) Relative Strength Index (RSI) is 54.93, creating a Neutral signal.
Protagonist Therapeutics’s (PTGX) Trend Strength Indicator (ADX) is 19.50, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) Commodity Channel Index (CCI) is 132.71, creating a Sell signal.
Protagonist Therapeutics’s (PTGX) Price Rate of Change (ROC) is 5.20, creating a Buy signal.

FAQ

Is PTGX a Buy, Hold, or Sell?
Based on PTGX’s technical indicators, PTGX is a Buy.
    What is PTGX’s RSI (14)?
    PTGX’s RSI (14) is 54.93, which suggests PTGX is a Neutral.
      What is PTGX’s MACD?
      PTGX’s MACD is -0.66, which suggests PTGX is a Sell.
        What is PTGX’s 5-day moving average?
        PTGX’s 5-day moving average is 82.39, which suggests PTGX is a Buy.
          What is PTGX’s 20-day moving average?
          PTGX 20-day moving average is 82.56, which suggests PTGX is a Buy.
            What is PTGX’s 50-day moving average?
            PTGX’s 50-day moving average is 86.09, which suggests PTGX is a Sell.
              What is PTGX’s 200-day moving average?
              PTGX’s 200-day moving average is 65.70, which suggests PTGX is a Buy.
                What is PTGX’s Williams % R (14)?
                PTGX’s Williams % R (14) is -18.98, which suggests PTGX is a Sell.
                  What is PTGX’s CCI (14)?
                  PTGX’s CCI (14) is 132.71, which suggests PTGX is a Sell.